High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Do women with polycystic ovary syndrome (PCOS) have an increased prevalence of moderate and severe depressive and anxiety symptoms compared with control women, and do these symptoms correlate with age, BMI, testosterone, hirsutism or insulin resistance (IR)? SUMMARY ANSWER: Women with PCOS have significantly increased odds of moderate and severe depressive and anxiety symptoms, independent of obesity, and the symptoms are weakly associated with age, BMI, elevated testosterone, hirsutism and IR. WHAT IS KNOWN ALREADY: Previous studies have reported that women with PCOS have an increased prevalence of mild depressive and anxiety symptoms or an increase in mean depression and anxiety scores, although these scores are usually within the normal range. Thus, it is therefore not clear whether these findings are clinically significant. The prevalence of moderate and severe depressive and anxiety symptoms, which require follow-up and would benefit from treatment, is not known in this population. STUDY DESIGN, SIZE, DURATION: A comprehensive systematic review (SR) was performed up to January 2016 and included 30 cross-sectional studies, representing 3050 subjects with PCOS and 3858 controls, from 10 different countries. The meta-analysis (MA) on depressive symptoms included 18 studies and the MA on anxiety symptoms included 9 studies. A separate SR identified 15 studies for the meta-regression examining the associations with PCOS-related symptoms or comorbidities. PARTICIPANTS/MATERIALS, SETTING, METHODS: All studies included adult women with PCOS, defined by the National Institutes of Health or Rotterdam criteria, and a control group without PCOS. Ovid, Embase, PsychInfo and Cochrane were searched up to January 2016. Included studies used a validated screening tool to compare the prevalence or mean scores of depressive and/or anxiety symptoms. Random effects MA was used to estimate the pooled odds ratio (OR) of depressive and anxiety symptoms. Sensitivity analyses of methodological characteristics and a meta-regression of the pooled standardized mean difference (SMD) to evaluate PCOS-related clinical and laboratory associations were performed. MAIN RESULTS AND THE ROLE OF CHANCE: Women with PCOS had increased odds of any depressive symptoms (OR: 3.78; 95% CI: 3.03-4.72; 18 studies) and of moderate/severe depressive symptoms (OR: 4.18; 95% CI: 2.68-6.52; 11 studies). Women with PCOS had increased odds of any anxiety symptoms (OR: 5.62; 95% CI: 3.22-9.80, nine studies) and of moderate/severe anxiety symptoms (OR: 6.55; 95% CI: 2.87, 14.93; five studies). When subjects were matched on BMI, women with PCOS still had higher odds of both depressive (OR: 3.25; 95% CI 1.73-6.09; four studies) and anxiety symptoms (OR: 6.30, 95% CI: 1.88-21.09; three studies). There was no substantial heterogeneity among studies in the overall MA on depressive symptoms (I2 = 22.4%, P = 0.19), but there was significant heterogeneity among studies in the analysis on anxiety symptoms (I2 = 59.6%, P= 0.01). In the meta-regression evaluating pooled SMDs between groups, women with PCOS and concurrent depression had higher mean values of age, BMI, hirsutism score and IR, while women with PCOS and concurrent anxiety had higher mean values of BMI, hirsutism score and free testosterone (P < 0.05 for all comparisons). LIMITATIONS, REASON FOR CAUTION: All studies were cross-sectional, thus we can only hypothesize that the diagnosis of PCOS precedes the diagnosis of depression and anxiety. There were large variations in methodological characteristics especially in the studies screening for anxiety; however, they only partly explained effect size variation. WIDER IMPLICATIONS OF THE FINDINGS: This evidence-synthesis analysis shows that PCOS diagnosis is associated with an increased risk of moderate and severe depressive and anxiety symptoms and suggests that providers should consider screening women with PCOS for both depression and anxiety. Although age, obesity, hyperandrogenism and IR do not explain the entire association, well-designed studies are needed to assess the impact of treatment of these factors on depressive and anxiety symptoms in women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): No funding was used for this study. There are no conflicts of interest. REGISTRATION NUMBER: N/A.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is concerning given the established evidence of increased depression, anxiety, eating disorders and other mental illnesses in those affected with PCOS [3, 8, 57–59].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [58]
In the citing paper
“This prevalence of eating disorders is relatively high compared to that found in other population studies that report a 0.3%-2.45% prevalence in those with PCOS.31,126,129,130”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [129]
In the citing paper
“Another meta-analysis estimated a prevalence of 36 % for depression in PCOS [69].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [69]
In the citing paper
“The risk of developing depression may be associated with higher BMI [70], although this association is weak.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [70]
In the citing paper
“A recent meta-analysis of depression rates among women with PCOS resulted in a median prevalence of depression of almost 37% compared to 14% in controls [8].”
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement
Siu, A. L., and the US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A. R., Gillman, M., Herzstein, J., et al. (2016) · JAMA · doi:10.1001/jama.2015.18392 · Cited by 1,407
Increased risk of depressive disorders in women with polycystic ovary syndrome
Hollinrake, E., Abreu, A., Maifeld, M., Van Voorhis, B. J., & Dokras, A. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.039 · Cited by 631
Self-citationAssociation of diabetes with anxiety: a systematic review and meta-analysis
Smith, K. J., Béland, M., Clyde, M., Gariépy, G., Pagé, V., Badawi, G., Rabasa-Lhoret, R., & Schmitz, N. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.11.013 · Cited by 447
Elsenbruch, S., Hahn, S., Kowalsky, D., Öffner, A. H., Schedlowski, M., Mann, K., & Janssen, O. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030562 · Cited by 437
ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
(2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181bd12cb · Cited by 436
The Potential Implications of a PCOS Diagnosis on a Woman's Long-Term Health Using Data Linkage
Hart, R., & Doherty, D. A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3886 · Cited by 391
Quality of life and psychological well being in polycystic ovary syndrome
Barnard, L., Ferriday, D., Guenther, N., Strauss, B., Balen, A. H., & Dye, L. (2007) · Human Reproduction · doi:10.1093/humrep/dem108 · Cited by 388
Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic
Chen, T.-H., Chang, S.-P., Tsai, C.-F., & Juang, K.-D. (2004) · Human Reproduction · doi:10.1093/humrep/deh414 · Cited by 365
Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis
Barry, J. A., Kuczmierczyk, A. R., & Hardiman, P. J. (2011) · Human Reproduction · doi:10.1093/humrep/der197 · Cited by 336
A systematic review and meta-analysis of the association between depression and insulin resistance
Kan, C., Silva, N., Golden, S. H., Rajala, U., Timonen, M., Stahl, D., & Ismail, K. (2013) · Diabetes Care · doi:10.2337/dc12-1442 · Cited by 322
Bromberger, J. T., Schott, L. L., Kravitz, H. M., Sowers, M., Avis, N. E., Gold, E. B., Randolph, J. F., & Matthews, K. A. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.55 · Cited by 320
Volgsten, H., Skoog Svanberg, A., Ekselius, L., Lundkvist, O., & Sundstrom Poromaa, I. (2008) · Human Reproduction · doi:10.1093/humrep/den154 · Cited by 303
Association between obesity and depression in middle-aged women
Simon, G. E., Ludman, E. J., Linde, J. A., Operskalski, B. H., Ichikawa, L., Rohde, P., Finch, E. A., & Jeffery, R. W. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.09.001 · Cited by 296
Chang, R. J., Heindel, J. J., & Dunaif, A. (2002) · CRC Press eBooks · doi:10.3109/9780203910948 · Cited by 262
Women with polycystic ovary syndrome are often depressed or anxious—A case control study
Månsson, M., Holte, J., Landin-Wilhelmsen, K., Dahlgren, E., Johansson, A., & Landén, M. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.06.003 · Cited by 260
Depression and Body Image among Women with Polycystic Ovary Syndrome
Himelein, M. J., & Thatcher, S. S. (2006) · Journal of Health Psychology · doi:10.1177/1359105306065021 · Cited by 248
Kerchner, A., Lester, W., Stuart, S. P., & Dokras, A. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.022 · Cited by 232
Self-citationWeiner, C. L., Primeau, M., & Ehrmann, D. A. (2004) · Psychosomatic Medicine · doi:10.1097/00006842-200405000-00011 · Cited by 231
Dokras, A., Clifton, S., Futterweit, W., & Wild, R. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318202b0a4 · Cited by 227
Self-citationThe epidemiology of generalized anxiety disorder in Europe
Lieb, R., Becker, E., & Altamura, C. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.010 · Cited by 227
Cesta, C. E., Månsson, M., Palm, C., Lichtenstein, P., Iliadou, A. N., & Landén, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.005 · Cited by 217
Veltman-Verhulst, S. M., Boivin, J., Eijkemans, M. J. C., & Fauser, B. J. C. M. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms029 · Cited by 215
Farrell, K., & Antoni, M. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.081 · Cited by 209
Dokras, A., Clifton, S., Futterweit, W., & Wild, R. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.10.022 · Cited by 209
Self-citationDeeks, A. A., Gibson-Helm, M. E., Paul, E., & Teede, H. J. (2011) · Human Reproduction · doi:10.1093/humrep/der071 · Cited by 202
Jedel, E., Waern, M., Gustafson, D., Landen, M., Eriksson, E., Holm, G., Nilsson, L., Lind, A.-K., Janson, P. O., & Stener-Victorin, E. (2010) · Human Reproduction · doi:10.1093/humrep/dep384 · Cited by 176
Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis.
Zhao, L., Zhu, Z., Lou, H., Zhu, G., Huang, W., Zhang, S., & Liu, F. (2016) · Oncotarget · doi:10.18632/oncotarget.9553 · Cited by 174
Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome
Cinar, N., Kizilarslanoglu, M. C., Harmanci, A., Aksoy, D. Y., Bozdag, G., Demir, B., & Yildiz, B. O. (2011) · Human Reproduction · doi:10.1093/humrep/der338 · Cited by 168
Disturbed stress responses in women with polycystic ovary syndrome
Benson, S., Arck, P., Tan, S., Hahn, S., Mann, K., Rifaie, N., Janssen, O. E., Schedlowski, M., & Elsenbruch, S. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.001 · Cited by 166
Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome
Benson, S., Janssen, O. E., Hahn, S., Tan, S., Dietz, T., Mann, K., Pleger, K., Schedlowski, M., Arck, P., & Elsenbruch, S. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.07.003 · Cited by 164
Dokras, A., Sarwer, D. B., Allison, K. C., Milman, L., Kris-Etherton, P. M., Kunselman, A. R., Stetter, C. M., Williams, N. I., Gnatuk, C. L., Estes, S. J., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1896 · Cited by 161
Self-citationHung, J.-H., Hu, L.-Y., Tsai, S.-J., Yang, A. C., Huang, M.-W., Chen, P.-M., Wang, S.-L., Lu, T., & Shen, C.-C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097041 · Cited by 152
Behboudi‐Gandevani, S., Tehrani, F. R., Dovom, M. R., Farahmand, M., Khomami, M. B., Noroozzadeh, M., Kabir, A., & Azizi, F. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2015.1117069 · Cited by 130
Moran, L., Gibson-Helm, M., Teede, H., & Deeks, A. (2010) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674820903477593 · Cited by 127
Psychological investigation in patients with polycystic ovary syndrome
Bazarganipour, F., Ziaei, S., Montazeri, A., Foroozanfard, F., Kazemnejad, A., & Faghihzadeh, S. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-141 · Cited by 116
Açmaz, G., Albayrak, E., Açmaz, B., Başer, M., Soyak, M., Zararsız, G., & İpekMüderris, İ. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/851815 · Cited by 114
Sleep disturbances in a community-based sample of women with polycystic ovary syndrome
Moran, L. J., March, W. A., Whitrow, M. J., Giles, L. C., Davies, M. J., & Moore, V. M. (2015) · Human Reproduction · doi:10.1093/humrep/deu318 · Cited by 98
Psychological parameters in the reproductive phenotypes of polycystic ovary syndrome
Moran, L., Deeks, A. A., Gibson‐Helm, M. E., & Teede, H. J. (2012) · Human Reproduction · doi:10.1093/humrep/des114 · Cited by 98
Clinical management guidelines for obstetrician-gynecologists. Polycystic ovary syndrome
Bulletin, A. P. (2009) · Obstetrics and Gynecology · Cited by 94
Adalı, E., Yıldızhan, R., Kurdoğlu, M., Kolusarı, A., Edirne, T., Şahin, H. G., Yıldızhan, B., & Kamacı, M. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600604 · Cited by 93
Holt, R. I. G., Phillips, D. I. W., Jameson, K. A., Cooper, C. C., Dennison, E. M., Peveler, R., & The Hertfordshire Cohort Study Group (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02742.x · Cited by 92
Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)
Bhattacharya, S. M., & Jha, A. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.09.025 · Cited by 88
Çınar, N., Harmanci, A., Demir, B., & Yıldız, B. O. (2012) · Human Reproduction · doi:10.1093/humrep/des113 · Cited by 87
Barry, J. A., Hardiman, P., Saxby, B. K., & Kuczmierczyk, A. R. (2011) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/0167482x.2011.568129 · Cited by 84
Clinician vs Self-ratings of Hirsutism in Patients With Polycystic Ovarian Syndrome
Pasch, L. A., He, S. Y., Huddleston, H. G., Cedars, M. I., Beshay, A. P., Zane, L. T., & Shinkai, K. (2016) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.0358 · Cited by 79
PCOS, Sexuality, and Clitoral Vascularisation: A Pilot Study
Battaglia, C., Nappi, R. E., Mancini, F., Cianciosi, A., Persico, N., Busacchi, P., Facchinetti, F., & Sisti, G. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01010.x · Cited by 75
Sexual dysfunction assessment and hormonal correlations in patients with polycystic ovary syndrome
Ercan, C. M., Çoksüer, H., Aydoğan, Ü., Alanbay, İ., Keskin, U., Karaşahin, K. E., & Basȩr, Ï. (2013) · International Journal of Impotence Research · doi:10.1038/ijir.2013.2 · Cited by 74
Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome
Livadas, S., Chaskou, S., Kandaraki, A., Skourletos, G., Economou, F., Christou, M., Boutzios, G., Karachalios, A., Zerva, A., Xyrafis, X., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04122.x · Cited by 70
Health-Related Quality of Life, Depression and Anxiety Correlate with the Degree of Hirsutism
Ekbäck, M., Lindberg, M., Benzein, E., & Årestedt, K. (2013) · Dermatology · doi:10.1159/000355356 · Cited by 68
Women's adjustment trajectories during IVF and impact on mental health 11–17 years later
Gameiro, S., van den Belt‐Dusebout, A. W., Smeenk, J. M. J., Braat, D. D. M., van Leeuwen, F. E., & Verhaak, C. M. (2016) · Human Reproduction · doi:10.1093/humrep/dew131 · Cited by 62
Gallinelli, A., Matteo, M. L., Volpe, A., & Facchinetti, F. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00601-9 · Cited by 60
Aşık, M., Altınbaş, K., Eroğlu, M., Karaahmet, E., Erbağ, G., Ertekin, H., & Şen, H. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.043 · Cited by 57
Annagür, B. B., Tazegül, A., Uğuz, F., Kerimoğlu, Ö. S., Tekinarslan, E., & Çelık, Ç. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.01.002 · Cited by 54
Putative role for insulin resistance in depression risk in polycystic ovary syndrome
Greenwood, E. A., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.05.019 · Cited by 53
Psychosocial Factors Associated with Polycystic Ovary Syndrome: a Case Control Study
Sayyah-Melli, M., Alizadeh, M., Pourafkari, N., Ouladsahebmadarek, E., Jafari-Shobeiri, M., Abbassi, J., Kazemi-Shishvan, M. A., & Sedaghat, K. (2015) · Journal of Caring Sciences · doi:10.15171/jcs.2015.023 · Cited by 52
Shi, X., Zhang, L., Fu, S., & Li, N. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1947-1 · Cited by 40
Biringer, E., Howard, L. M., Keßler, U., Stewart, R. J., & Mykletun, A. (2015) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/0167482x.2014.992411 · Cited by 40
Polikistik Over Sendromu Olan Kadınlarda Beden Algısı, Benlik Saygısı ve Depresif Belirtiler
Annagür, B. B., Tazegül, A., & Akbaba, N. (2014) · Nöro Psikiyatri Arşivi · doi:10.4274/npa.y6778 · Cited by 39
Predictors of depression in women with polycystic ovary syndrome
Naqvi, S. H., Moore, A. D., Bevilacqua, K., Lathief, S., Williams, J. W., Naqvi, N., & Pal, L. (2014) · Archives of Women s Mental Health · doi:10.1007/s00737-014-0458-z · Cited by 38
Rahiminejad, M. E., Moaddab, A., Rabiee, S., Esna‐Ashari, F., Borzouei, S., & Hosseini, S. M. (2014) · Europe PMC (PubMed Central) · Cited by 32
Prevalence of Psychiatric Morbidity in Females amongst Infertile Couples- A Hospital Based Report
Sethi, P., Sharma, A., Goyal, L. D., & Kaur, G. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19639.8090 · Cited by 30
Depression in relation to biochemical parameters and age in women with polycystic ovary syndrome
Klimczak‐Tomaniak, D., Szlendak-Sauer, K., & Radowicki, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.10.028 · Cited by 28
Evaluation of hand functions in women with polycystic ovary syndrome
Soyupek, F., Güney, M., Eriş, S., Çerçi, S. S., Yıldız, S., & Mungan, T. (2008) · Gynecological Endocrinology · doi:10.1080/09513590802288218 · Cited by 25
Polycystic Ovary Syndrome and Chronic Inflammation: Pharmacotherapeutic Implications
Sirmans, S. M., Weidman-Evans, E., Everton, V., & Thompson, D. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q514 · Cited by 25
Milman, L. W., Sammel, M. D., Barnhart, K. T., Freeman, E. W., & Dokras, A. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.612 · Cited by 23
Self-citationHaydardedeo, B., Kılıçdağ, E. B., & Ba, T. (2008) · Cited by 22
Bipolar disorder in women with polycystic ovarian syndrome (PCO).
Tanha, F. D., Rashidi, B. H., Ghajarzadeh, M., & Noorbala, A. A. (2014) · PubMed · Cited by 20
HARMANCI, H., Hergüner, S., & Toy, H. (2012) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2013260205 · Cited by 7
The Frequency of Fibromyalgia Syndrome in Patients with Polycystic Ovary Syndrome
Soyupek, F., Yıldız, S., Akkuş, S., Güney, M., Mungan, M. T., & Eriş, S. (2010) · Journal of Musculoskeletal Pain · doi:10.3109/10582452.2010.483968 · Cited by 6
Altınkaya, S. Ö., Nergiz, S., Küçük, M., & Yüksel, H. (2014) · Turkiye Klinikleri Journal of Gynecology and Obstetrics · Cited by 3
Research works printed but not linked: 3
- 2014, Body image, self-esteem and depressive symptomatology in women with polycystic ovary syndrome, Noropsikiyatri Arsivi, 51, 129
- 2013, Psychiatric symptoms in women with polycystic ovary syndrome, Dusunen Adam, 26, 157
- 1992, Polycystic ovary syndrome, 377
Cited by
Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., Kraft, P., Lin, N., Huang, H., Broer, L., et al. (2018) · PLOS Genetics · doi:10.1371/journal.pgen.1007813 · Cited by 619
Update on PCOS: consequences, challenges, and guiding treatment
Hoeger, K. M., Dokras, A., & Piltonen, T. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa839 · Cited by 610
Self-citationComorbid depression in medical diseases
Gold, S. M., Köhler-Forsberg, O., Moss-Morris, R., Mehnert, A., Miranda, J. J., Bullinger, M., Steptoe, A., Whooley, M. A., & Otte, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0200-2 · Cited by 534
Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome
Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa010 · Cited by 348
Adolescent polycystic ovary syndrome according to the international evidence-based guideline
Peña, A. S., Witchel, S. F., Hoeger, K. M., Oberfield, S. E., Vogiatzi, M. G., Misso, M., Garad, R., Dabadghao, P., & Teede, H. (2020) · BMC Medicine · doi:10.1186/s12916-020-01516-x · Cited by 301
Metadata
- Authors
- Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A.
- Affiliations
- Hospital of the University of Pennsylvania (US)
- Corresponding author
- Cooney, Laura G.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-09
- Volume
- 32
- Issue
- 5
- Pages
- 1075-1091
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2592269563
- Cited by
- 631
- References
- 80
- Citations by year
- 2026: 95 · 2025: 94 · 2024: 63 · 2023: 81 · 2022: 70 · 2021: 77 · 2020: 56 · 2019: 49 · 2018: 35 · 2017: 10
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- polycystic ovary syndrome, depressive symptoms, anxiety symptoms, depression prevalence, anxiety prevalence, obesity, insulin resistance, testosterone, hirsutism, body mass index, age, women's mental health, comorbidities, Rotterdam criteria, NIH criteria, screening tool, meta-regression, standardized mean difference
- MeSH terms
- Anxiety, Depression, Female, Humans, Polycystic Ovary Syndrome, Severity of Illness Index, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.